BACKGROUND: Tissue inhibitor of metalloproteinases-3 (TIMP3) is the third member of the TIMP family of proteins, believed to play a significant role in controlling extracellular matrix remodeling. MATERIALS AND METHODS: Differential screening of a human breast carcinoma cDNA library using substracted and PCR-amplified cDNA probes identified a 4.6-kb TIMP3 cDNA, which was used for further cDNA library screenings, Northern blot hybridizations, and the synthesis of riboprobes for in situ RNA hybridization analyses. RESULTS: The 4.6-kb full-length TIMP3 cDNA contains 3.7 kb of 3'-untranslated sequence. Additional TIMP3 cDNAs subsequently identified were colinear with the original sequence, but revealed use of four different polyadenylation signals within the 3'-untranslated region, which accounted for the 4.6-, 2.7-, 2.5-, and 2.1-kb TIMP3 transcripts noted in this and in previous studies. In situ RNA hybridizations demonstrated that in breast carcinoma the TIMP3 gene was predominantly expressed by fibroblastic cells within the tumor stroma adjacent to cancer cells. TIMP3 transcripts were also strongly detected in fibroblastic decidual cells of pregnant endometrium. CONCLUSIONS: Modulating the length of the 3'-untranslated region may represent a mechanism by which TIMP3 gene expression is controlled in tissues. The strong expression of the TIMP3 gene by fibroblastic cells in breast carcinoma supports the importance of tumor stroma as a source of factors influencing human carcinoma growth and progression.
BACKGROUND:Tissue inhibitor of metalloproteinases-3 (TIMP3) is the third member of the TIMP family of proteins, believed to play a significant role in controlling extracellular matrix remodeling. MATERIALS AND METHODS: Differential screening of a humanbreast carcinoma cDNA library using substracted and PCR-amplified cDNA probes identified a 4.6-kb TIMP3 cDNA, which was used for further cDNA library screenings, Northern blot hybridizations, and the synthesis of riboprobes for in situ RNA hybridization analyses. RESULTS: The 4.6-kb full-length TIMP3 cDNA contains 3.7 kb of 3'-untranslated sequence. Additional TIMP3 cDNAs subsequently identified were colinear with the original sequence, but revealed use of four different polyadenylation signals within the 3'-untranslated region, which accounted for the 4.6-, 2.7-, 2.5-, and 2.1-kb TIMP3 transcripts noted in this and in previous studies. In situ RNA hybridizations demonstrated that in breast carcinoma the TIMP3 gene was predominantly expressed by fibroblastic cells within the tumor stroma adjacent to cancer cells. TIMP3 transcripts were also strongly detected in fibroblastic decidual cells of pregnant endometrium. CONCLUSIONS: Modulating the length of the 3'-untranslated region may represent a mechanism by which TIMP3 gene expression is controlled in tissues. The strong expression of the TIMP3 gene by fibroblastic cells in breast carcinoma supports the importance of tumor stroma as a source of factors influencing humancarcinoma growth and progression.
Authors: C Wolf; N Rouyer; Y Lutz; C Adida; M Loriot; J P Bellocq; P Chambon; P Basset Journal: Proc Natl Acad Sci U S A Date: 1993-03-01 Impact factor: 11.205
Authors: Kimberly Walter; Noriyuki Omura; Seung-Mo Hong; Margaret Griffith; Audrey Vincent; Michael Borges; Michael Goggins Journal: Clin Cancer Res Date: 2010-03-09 Impact factor: 12.531
Authors: M C Rio; O Lefebvre; M Santavicca; A Noël; M P Chenard; P Anglard; J A Byrne; A Okada; C H Régnier; R Masson; J P Bellocq; P Basset Journal: J Mammary Gland Biol Neoplasia Date: 1996-04 Impact factor: 2.673
Authors: J-W Kornfeld; S Meder; M Wohlberg; R E Friedrich; T Rau; L Riethdorf; T Löning; K Pantel; S Riethdorf Journal: Br J Cancer Date: 2010-11-23 Impact factor: 7.640
Authors: Eleni Mylona; Christina Magkou; Ioanna Giannopoulou; George Agrogiannis; Sofia Markaki; Antonios Keramopoulos; Lydia Nakopoulou Journal: Breast Cancer Res Date: 2006 Impact factor: 6.466
Authors: D G Powe; J L Brough; G I Carter; E M Bailey; W G Stetler-Stevenson; D R Turner; R E Hewitt Journal: Br J Cancer Date: 1997 Impact factor: 7.640